Roche reaffirmed that sales of COVID-19 medicines and diagnostics would decrease by about 2 billion Swiss francs this year to around 5 billion francs, even as new coronavirus subvariants fuel a resurgence in infections.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/p8Dh7m2
No comments:
Post a Comment